DE69916266D1 - Prostaglandine und benzylalcohol enthaltende lösung - Google Patents

Prostaglandine und benzylalcohol enthaltende lösung

Info

Publication number
DE69916266D1
DE69916266D1 DE69916266T DE69916266T DE69916266D1 DE 69916266 D1 DE69916266 D1 DE 69916266D1 DE 69916266 T DE69916266 T DE 69916266T DE 69916266 T DE69916266 T DE 69916266T DE 69916266 D1 DE69916266 D1 DE 69916266D1
Authority
DE
Germany
Prior art keywords
benzyl alcohol
prostaglandine
containing solution
alcohol containing
new formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69916266T
Other languages
English (en)
Other versions
DE69916266T2 (de
Inventor
G Re
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of DE69916266D1 publication Critical patent/DE69916266D1/de
Publication of DE69916266T2 publication Critical patent/DE69916266T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69916266T 1998-06-17 1999-06-08 Prostaglandine und benzylalcohol enthaltende lösung Expired - Lifetime DE69916266T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/094,985 US6187818B1 (en) 1998-06-17 1998-06-17 Prostaglandins formulation and process
US94985 1998-06-17
PCT/US1999/011808 WO1999065527A1 (en) 1998-06-17 1999-06-08 Solution comprising prostaglandins and benzyl alcohol

Publications (2)

Publication Number Publication Date
DE69916266D1 true DE69916266D1 (de) 2004-05-13
DE69916266T2 DE69916266T2 (de) 2005-03-10

Family

ID=22248341

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69916266T Expired - Lifetime DE69916266T2 (de) 1998-06-17 1999-06-08 Prostaglandine und benzylalcohol enthaltende lösung

Country Status (15)

Country Link
US (1) US6187818B1 (de)
EP (1) EP1085907B1 (de)
JP (1) JP4472175B2 (de)
KR (1) KR100608176B1 (de)
CN (1) CN1188170C (de)
AT (1) ATE263576T1 (de)
AU (1) AU752047B2 (de)
CA (1) CA2331284C (de)
DE (1) DE69916266T2 (de)
DK (1) DK1085907T3 (de)
ES (1) ES2219036T3 (de)
HK (1) HK1036413A1 (de)
NZ (1) NZ508947A (de)
PT (1) PT1085907E (de)
WO (1) WO1999065527A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4834224B2 (ja) 1999-03-05 2011-12-14 デューク ユニバーシティ Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
CN108078998B (zh) * 2017-11-23 2018-09-21 宁波三生生物科技有限公司 一种氨基丁三醇前列腺素F2α注射液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3885041A (en) * 1970-12-28 1975-05-20 Searle & Co Antiinflammatory use of prostaglandins
US3917864A (en) 1973-02-12 1975-11-04 Sultanali M M Karim Use of prostaglandins E and F for induction of labor
US3903297A (en) 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
EP0268066A3 (de) 1986-10-17 1990-07-11 Syntex (U.S.A.) Inc. Fertilitäts-Kontrolle und Uterin-Therapie bei Hunden mit LHRH-Antagonisten
AR002194A1 (es) 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.

Also Published As

Publication number Publication date
NZ508947A (en) 2003-05-30
ATE263576T1 (de) 2004-04-15
WO1999065527A1 (en) 1999-12-23
CN1301178A (zh) 2001-06-27
PT1085907E (pt) 2004-08-31
ES2219036T3 (es) 2004-11-16
KR100608176B1 (ko) 2006-08-04
CA2331284A1 (en) 1999-12-23
CA2331284C (en) 2009-09-22
DE69916266T2 (de) 2005-03-10
JP2002518348A (ja) 2002-06-25
KR20010052944A (ko) 2001-06-25
AU5079699A (en) 2000-01-05
AU752047B2 (en) 2002-09-05
CN1188170C (zh) 2005-02-09
US6187818B1 (en) 2001-02-13
HK1036413A1 (en) 2002-01-04
JP4472175B2 (ja) 2010-06-02
DK1085907T3 (da) 2004-06-21
EP1085907A1 (de) 2001-03-28
EP1085907B1 (de) 2004-04-07

Similar Documents

Publication Publication Date Title
NO304261B1 (no) Preparat omfattende en lipofil forbindelse
NZ332625A (en) Concentrated antibody preparation containing greater than 100 mg/ml of the antibody
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
MX9603560A (es) Composiciones de prostaglandinas estables en almacenamiento.
NZ294464A (en) Stable, aqueous formulation having high biological alpha-type interferon activity buffered from 4.5 to 7.1 and comprising chelating agent and a polyoxyethylene sorbitan monooleate, formulation free from human blood-derived products
DK1308170T3 (da) Törret blodfaktorpræparat indeholdende trehalose
DE59800863D1 (de) Transdermale, orale und intravenöse zubereitungen von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
SE9800729D0 (sv) New topical formulation I
DE69916266D1 (de) Prostaglandine und benzylalcohol enthaltende lösung
CO4700479A1 (es) Agentes antifungicos de peptidos ciclicos
FI910112A0 (fi) Preparat foer lokalt bruk.
IT1260155B (it) Uso terapeutico della fosforil-l-serina-n-acil-sfingosina
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
DK0647129T3 (da) Præparat til topisk anvendelse
AU618896B2 (en) Stable solutions of rebeccamycin analog and preparation thereof
SE8704240L (sv) Analgetiska preparat
AU2001258859A1 (en) Pralmorelin-containing nasal drop preparations
FR2567756B1 (fr) Nouvelles compositions pharmaceutiques contenant comme ingredient actif l'acetyl-10 triacetoxy-1,8,9 anthracene

Legal Events

Date Code Title Description
8364 No opposition during term of opposition